Barry Byrne, Ph.D., M.D.
Director, University of Florida Powell Gene Therapy Center
Professor, Molecular Genetics & Microbiology
Professor and Associate Chair, Department of Pediatrics, University of Florida
Co-Leader, Duchenne Muscular Dystrophy Rare Disease Team
Member, OneFlorida Steering Committee
Barry Byrne is the UF associate chair of the Department of Pediatrics and director of the UF Powell Center for Rare Disease Research. Byrne is a clinician scientist who is studying a variety of rare diseases with specific attention to developing therapies for inherited muscle disease. As a pediatric cardiologist, his focus is on conditions that lead to skeletal muscle weakness and problems in heart and respiratory function. His research team has been developing new therapies using a missing cellular protein or the corrective gene to restore muscle function in Pompe and other inherited myopathies. Byrne co-leads the Duchenne Muscular Dystrophy (DMD) Rare Disease Team and serves on the OneFlorida Steering Committee. As co-leader of the DMD Rare Disease Team, he works in collaboration with Krista Vandenborne, PT, Ph.D., on the development of computable phenotypes. He also collaborates with DuchenneConnect and the Phelan-McDermid Syndrome Data Network (PMS-DN), both of which are PCORI Patient Powered Research Networks. Finally, he serves as a liaison to industry representatives focused on rare disease, including Solid Ventures.